The Cancer Prevention Program is built around the idea that changing certain lifestyle or environmental factors can lower cancer incidence and improve survival. We investigate cancer etiology and risk factors through clinic- and community-based studies in targeted populations.
As part of our long-term objectives, we develop and test novel screening and surveillance methods that can be readily translated into clinical practice and train the next generation of scientists in prevention research.
Researchers are studying a subtype of colorectal cancer (CRC) that develops via the serrated pathway with a goal of determining future prevention strategies and advancing treatment for CRC.
Funding Agency: National Institutes of Health
Contact: Rachel Malen, rmalen@fredhutch.org
Researchers are determining the cost-effectiveness of cord blood vs. haplo matched relatives using clinical information from the Bone Marrow Transplant (BMT) Clinical Trials Network (CTN) and insurance claims data.
Funding Agency: National Institutes of Health
Contact: Jordan Steelquist, jsteelq@fredhutch.org
The MsFLASH network conducts clinical trials aimed at finding promising treatments for the most common symptoms of menopause.
Researchers tested the efficacy and safety of beta-carotene and retinyl palmitate in people at high risk for lung cancer in a randomized, double-blind, placebo-controlled trial. Active follow-up of trial. participants ended on June of 2005; however, the program continues to support the extensive biological repository and ancillary studies that use CARET samples and data.
Contact: Jackie Dahlgren, jdahlgre@fredhutch.org
Researchers are developing a decision model designed to evaluate the cost effectiveness of multiplex NGS testing vs. usual care. They plan to pair the decision model with information theory to identify the most efficient and impactful study designs.
Funding Agency: Personalized Medicine Coalition
Contact: Jordan Steelquist, jsteelq@fredhutch.org
The goal of the project is to build and enhance community capacity and infrastructure on childhood obesity initiatives in the Lower Yakima Valley, Washington.
Funding Agency: National Institute on Minority Health and Health Disparities
Contact: Sonia Bishop, sbishop@fredhutch.org
Working with biological specimens, medical records and interviews, researchers investigate how genetic, environmental and lifestyle factors effects the incidence of colon and rectal cancers.
Funding Agency: National Institutes of Health
Contact: Rachel Malen, rmalen@fredhuthc.org
To test the effects of in-person and e-communication (e.g., text, email) interventions on improving diet and physical activity among Latina breast cancer survivors.
Funding Agency: National Institutes of Health / National Cancer Institute
Contact: Lisa Levy, llevy@fredhutch
Researchers compare the differences in cost and quality of life when using allogeneic stem cell transplant versus hypomethylating agents for patients aged 50 to 75 with myelodysplastic syndrome.
Funding Agency: National Institutes of Health
Contact: Jordan Steelquist, jsteelq@fredhutch.org
Using the data from the 12,000 Carotene and Retinol Efficacy Trial (CARET) participants, this study looks at the effects of both diet and dietary supplements, as well as polymorphisms in oxidative stress regulatory genes, on prostate cancer risk.
Funding Agency: National Cancer Institute
Contact: Diana Lowry, dlowry@fredhutch.org
Program Operations Director
Kelly Ambrose
Phone: 206.667.7726
kambrose@fredhutch.org
Assistant to the Program Head
Elizabeth Cox
Phone: 206.667.5755
eacox@fredhutch.org
The Cancer Prevention Program is located at the Robert W. Day Campus in the South Lake Union neighborhood of Seattle.
Mailing address:
Fred Hutchinson Cancer Research Center
Cancer Prevention Program
1100 Fairview Ave N, M3-B232
P.O. Box 1024
Seattle, WA 98109-1024
The UW Box number is 35808. When using box number, follow with mail stop.